Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I Chacón

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Medicina Clinica|October 24, 1992
[Comparative study of the survival of gastric B-cell lymphoma of mucosal origin with respect to lymph node lymphoma of similar histology]M A Cruz, J L Orradre, J Berruga, et al.
American Journal of Clinical Oncology|June 1, 1997
Treatment of superior and inferior vena cava syndromes of malignant cause with Wallstent catheter placed percutaneouslyJ I Chacón López-Muñiz, L García García, C Lanciego Pérez, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2005
Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancerJavier Castro de Carpeño, M González Barón, J Aguiar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 27, 2025
CDK4/6 inhibitors for metastatic breast cancer in routine clinical practice in Spain: survey of patterns of use and oncologists' perceptionsF Moreno, V Iranzo, I Álvarez, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Treatment of metastatic malignant melanoma with cisplatin plus tamoxifenJ Feliu, M González Barón, J I Chacón, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II studyJ Feliu, G Martin, J Lizón, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepamM González Barón, J I Chacón, C García Girón, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2019
SEOM clinical guidelines in advanced and recurrent breast cancer (2018)J I Chacón López-Muñiz, L de la Cruz Merino, J Gavilá Gregori, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 3, 2014
Preventive treatments for breast cancer: recent developmentsJ E Alés-Martínez, A Ruiz, J I Chacón, et al.
Journal of Patient-Reported Outcomes|December 23, 2019
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM studyA Barnadas, M Muñoz, M Margelí, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Medicina Clinica|October 24, 1992
[Comparative study of the survival of gastric B-cell lymphoma of mucosal origin with respect to lymph node lymphoma of similar histology]M A Cruz, J L Orradre, J Berruga, et al.
American Journal of Clinical Oncology|June 1, 1997
Treatment of superior and inferior vena cava syndromes of malignant cause with Wallstent catheter placed percutaneouslyJ I Chacón López-Muñiz, L García García, C Lanciego Pérez, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2005
Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancerJavier Castro de Carpeño, M González Barón, J Aguiar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 27, 2025
CDK4/6 inhibitors for metastatic breast cancer in routine clinical practice in Spain: survey of patterns of use and oncologists' perceptionsF Moreno, V Iranzo, I Álvarez, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Treatment of metastatic malignant melanoma with cisplatin plus tamoxifenJ Feliu, M González Barón, J I Chacón, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II studyJ Feliu, G Martin, J Lizón, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepamM González Barón, J I Chacón, C García Girón, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2019
SEOM clinical guidelines in advanced and recurrent breast cancer (2018)J I Chacón López-Muñiz, L de la Cruz Merino, J Gavilá Gregori, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 3, 2014
Preventive treatments for breast cancer: recent developmentsJ E Alés-Martínez, A Ruiz, J I Chacón, et al.
Journal of Patient-Reported Outcomes|December 23, 2019
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM studyA Barnadas, M Muñoz, M Margelí, et al.
Pageof 2